BRIEF published on 07/31/2025 at 09:22, 1 year 1 month ago Sensorion annonce sa participation à des conférences d'investisseurs Biotechnologie Conférences Investisseurs Sensorion Thérapies Auditives Septembre-Octobre 2025
BRIEF published on 07/31/2025 at 09:22, 1 year 1 month ago Sensorion Announces Participation in Investor Conferences Biotechnology Investor Conferences Sensorion Hearing Therapies September-October 2025
PRESS RELEASE published on 07/31/2025 at 09:17, 1 year 1 month ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à plusieurs conférences investisseurs à venir en septembre et octobre 2025. La société présentera ses avancées dans le domaine de la biotechnologie et des thérapies pour la perte auditive Biotechnologie Conférences Investisseurs Sensorion Perte Auditive Thérapies Auditives
BRIEF published on 07/01/2025 at 07:35, 1 year 2 months ago Sensorion Reports Positive Preliminary Data from Audiogene Phase 1/2 Trial Gene Therapy Sensorion SENS-501 Congenital Deafness Audiogene Trial
BRIEF published on 07/01/2025 at 07:35, 1 year 2 months ago Sensorion publie des données préliminaires positives issues de l'essai de phase 1/2 d'Audiogene Thérapie Génique Sensorion SENS-501 Surdité Congénitale Essai Audiogene
PRESS RELEASE published on 07/01/2025 at 07:30, 1 year 2 months ago Inside Information / Other news releases Sensorion announces positive data from the first cohort of the Audiogene Phase 1/2 Gene Therapy Clinical Trial, showing safety and hearing improvement in toddlers. Second cohort recruitment near completion Gene Therapy Clinical Trial Sensorion Audiogene Hearing Improvement
PRESS RELEASE published on 07/01/2025 at 07:30, 1 year 2 months ago Informations privilégiées / Autres communiqués Sensorion annonce des données préliminaires positives de la première cohorte de l'essai clinique de Phase 1/2 de thérapie génique Audiogene évaluant le SENS-501 pour traiter une forme spécifique de surdité congénitale Sécurité Thérapie Génique Sensorion Surdité Audiogene
BRIEF published on 05/13/2025 at 07:35, 1 year 4 months ago Sensorion Announces Approval of Shareholders’ Meeting Resolutions Biotechnology Gene Therapy Shareholder Resolutions Sensorion Hearing Loss Therapy
BRIEF published on 05/13/2025 at 07:35, 1 year 4 months ago Sensorion annonce l'approbation des résolutions de l'assemblée générale des actionnaires Biotechnologie Thérapie Génique Sensorion Résolutions Des Actionnaires Thérapie De La Perte Auditive
PRESS RELEASE published on 05/13/2025 at 07:30, 1 year 4 months ago Inside Information / Other news releases Sensorion announces successful adoption of all resolutions at Combined General Meeting. Results available on company's website Biotechnology Resolutions Combined General Meeting Sensorion Hearing Loss
Published on 09/17/2026 at 22:15, 1 hour 42 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/17/2026 at 22:15, 1 hour 42 minutes ago Vanta Attends 2026 All-In Summit in Los Angeles, a Leading Gathering of Business, Investment and Industry Leaders
Published on 09/17/2026 at 22:05, 1 hour 52 minutes ago Loop Industries Forms Strategic Alternatives Committee to Maximize Shareholder Value
Published on 09/17/2026 at 15:55, 8 hours 2 minutes ago Empress Announces Agreement to Acquire Tongon Gold Stream and Secures Debt Financing
Published on 09/17/2026 at 15:25, 8 hours 32 minutes ago AIAI Holdings' Constellation Network Launches Dôr Patient Journey with Proactive MD(R), Expanding Transformational AI In Healthcare
Published on 09/17/2026 at 19:00, 4 hours 57 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 4 hours 58 minutes ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 5 hours 32 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 5 hours 47 minutes ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 6 hours 11 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:40, 6 hours 17 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/17/2026 at 17:40, 6 hours 17 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
